Skip to content

EGEIRO PHARMA

Open bankruptcy
Public limited companyfounded 2017Avenue Jean Mermoz 32, 6041 Charleroi, BelgiumKBO/BCE: BE 0684.906.013

A bankruptcy procedure is open for EGEIRO PHARMA according to publications in the Belgian Official Gazette; trustee: Pierre-Emmanuel Cornil.

Summary

The 2023 annual accounts show equity of €6.0m and a net result of -€1.6m.

EGEIRO PHARMAOpen bankruptcy

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

  • THERAVET US A, INC (Corporation)USsubsidiary
    Equity -USD 178,770Result -USD 9,301
    100%+ 100% via subsidiaries

According to the 2023 annual accounts of EGEIRO PHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

1 connected company
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
BioSenic
Shared corporate director
→